Periodontal disease supplement protocol — what the evidence shows for gum health
Periodontal disease — gingivitis progressing to periodontitis — is a chronic bacterial inflammatory disease of the structures supporting the teeth. Most of what matters is mechanical: thorough daily plaque disruption (brushing, interdental cleaning), regular professional debridement, and treatment of pockets and bone loss by a dentist or periodontist. The supplement layer is a small adjunct, not a treatment. Vitamin D, vitamin C, CoQ10, and omega-3 each have modest trial evidence as adjuncts to scaling and root planing; none replace the mechanical work.
What actually has trial evidence as an adjunct
Vitamin D3 (in confirmed deficiency)
2,000–4,000 IU/day to a 25-OH-D target of 30–50 ng/mL
Vitamin D status is consistently associated with periodontal health in observational studies; low 25-OH-D is over-represented in periodontitis cohorts. Several small RCTs of vitamin D supplementation as an adjunct to scaling and root planing show modestly better pocket depth reduction and clinical attachment gain compared to SRP alone. Test 25-OH-D first; supplement to target.
Vitamin C (moderate dose)
200–500 mg/day; higher doses don't help and can cause GI upset
Vitamin C is required for collagen synthesis in periodontal ligament and gingival tissue. Frank deficiency (scurvy) causes severe gingival bleeding. Most adults are not deficient; supplementation in deficient or marginal users supports healing during periodontal therapy. Avoid mega-doses (>1 g/day) — no additional benefit, more GI side effects.
CoQ10 (oral; topical has separate small data)
100–200 mg/day ubiquinone or ubiquinol with a fatty meal
CoQ10 has been studied as both an oral adjunct and a topical gel application. Several small trials suggest modest reduction in pocket depth and bleeding on probing as an adjunct to SRP; evidence is heterogeneous and effect sizes are small. Reasonable in chronic periodontitis as part of a comprehensive plan, but not a primary treatment.
Omega-3 EPA/DHA
1.5–2 g EPA+DHA/day combined
The Elkhouli 2011 RCT and subsequent work suggest omega-3 plus low-dose aspirin (under cardiology guidance) may enhance periodontal treatment outcomes. Effect sizes are modest. Reasonable adjunct in users without bleeding-risk concerns.
Probiotics (Lactobacillus reuteri specifically)
Daily lozenge providing L. reuteri DSM 17938 or ATCC PTA 5289 strains; 8–12 week trial
Probiotic lozenges containing specific L. reuteri strains have small trial evidence in periodontitis adjunctive use, with reductions in gingival bleeding and pocket depth. Strain-specific; not all probiotics deliver this effect. Reasonable layered onto SRP and mechanical hygiene.
What dominates over supplements — the actual treatment
- Daily mechanical plaque removal — brushing twice daily with a soft brush (electric brushes generally outperform manual); interdental cleaning (floss, interdental brushes, water flossers depending on anatomy and operator skill).
- Scaling and root planing (SRP) — non-surgical mechanical debridement; the foundation of periodontal therapy in moderate-to-severe disease.
- Maintenance recall — typically every 3 months in active periodontal patients; the difference between 3-month and 6-month maintenance is large in disease progression.
- Smoking cessation — smoking is the largest modifiable risk factor for periodontitis; even modest reduction improves outcomes.
- Diabetes control — periodontal disease and diabetes have a bidirectional relationship; HbA1c control improves periodontal outcomes and vice versa.
- Surgical periodontal therapy — for deep pockets and bony defects that don't respond to non-surgical care; under periodontist care.
- Adjunctive antimicrobials — local-delivery antibiotics (minocycline gel, chlorhexidine chip) and short-course systemic antibiotics in selected cases.
What to skip
- "Oil pulling" for periodontitis — small effects on plaque vs control; does not arrest periodontitis; not a substitute for mechanical hygiene.
- Activated charcoal toothpaste — abrasive; increases enamel wear and gingival recession risk; no periodontal benefit.
- Mega-dose vitamin C — does not improve outcomes beyond moderate-dose supplementation in deficient users; risk of oxalate kidney stones at chronic high doses.
- Generic "gum health" supplement blends — typically sub-therapeutic doses of multiple ingredients with marketing emphasis. Use single-ingredient products at trial-cited doses if indicated.
- Excessive use of alcohol-based mouthwash — disturbs oral microbiome; not a substitute for mechanical cleaning. Chlorhexidine has a role in short-term post-surgical or active disease management but is not for indefinite daily use.
- Vitamin K2 in users on warfarin — interaction with anticoagulation; coordinate with prescriber.
What to track
Periodontal charting (pocket depths, bleeding on probing, clinical attachment levels) is the standard objective measure; reassessed by the dentist or periodontist at maintenance visits. Subjective markers (bleeding when brushing or flossing, gum tenderness, halitosis) are reasonable interim trackers. Supplement adjuncts are best layered after SRP and active disease control; their effect is small relative to the mechanical work.